Article Information
History
- October 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tariq O. Faquih1,*,
- Elvire N. Landstra2,*,
- Astrid van Hylckama Vlieg1,
- N.Ahmad Aziz2,3,
- Ruifang Li-Gao1,4,
- Renée de Mutsert1,
- Frits R. Rosendaal1,
- Raymond Noordam5,
- Diana van Heemst5,
- Dennis O. Mook-Kanamori1,6,
- Ko Willems van Dijk7,8,9 and
- Monique M.B. Breteler2,10,#
- 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
- 2Population Health Sciences, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany
- 3Department of Neurology, Faculty of Medicine, University of Bonn, Bonn, Germany
- 4Metabolon, Inc. Morrisville, North Carolina, United State of America
- 5Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
- 6Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
- 7Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
- 8Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
- 9Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
- 10Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn, Germany
- ↵#Corresponding author:
Monique M.B. Breteler, Monique.Breteler{at}dzne.de, Venusberg-Campus 1, Building 99, 53127 Bonn, Germany
↵* Authors contributed equally to this project
Posted October 19, 2023.
Per- and polyfluoroalkyl substances concentrations are associated with an unfavorable cardio-metabolic risk profile: findings from two population-based cohort studies
